Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6413087rdf:typepubmed:Citationlld:pubmed
pubmed-article:6413087lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6413087lifeskim:mentionsumls-concept:C0023212lld:lifeskim
pubmed-article:6413087lifeskim:mentionsumls-concept:C0013030lld:lifeskim
pubmed-article:6413087lifeskim:mentionsumls-concept:C0019010lld:lifeskim
pubmed-article:6413087lifeskim:mentionsumls-concept:C0017887lld:lifeskim
pubmed-article:6413087lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:6413087lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6413087lifeskim:mentionsumls-concept:C0348016lld:lifeskim
pubmed-article:6413087lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:6413087pubmed:issue4lld:pubmed
pubmed-article:6413087pubmed:dateCreated1983-11-23lld:pubmed
pubmed-article:6413087pubmed:abstractTextHemodynamic effects of dopamine and intravenous nitroglycerin alone, and in combination, were studied in 27 patients with severe left ventricular failure. Dopamine alone increased cardiac index from 1.8 to 2.5 l/min/m2 but also increased wedge pressure from 24 to 30 mm Hg and heart rate from 88 to 101 beats/min. Arterial oxygen saturation fell from 92% to 87% (p less than .001). Nitroglycerin alone had a lesser effect on cardiac index (1.8 to 2.2 l/min/m2) but decreased wedge pressure from 26 to 16 mm Hg and heart rate from 91 to 86 beats/min. Arterial oxygen saturation fell from 91% to 90% (NS). Combined dopamine and nitroglycerin administration resulted in optimal hemodynamics, with cardiac index of 2.9 l/min/m2, wedge pressure of 17 mm Hg, and heart rate of 96 beats/min. Arterial oxygen saturation remained low at 88% in spite of the reduction in left ventricular filling pressure, which probably reflects increased intrapulmonary right-to-left shunting coupled with increased pulmonary blood flow. These results suggest that the combination of dopamine with intravenous nitroglycerin should be considered for patients with severe left ventricular dysfunction who require temporary pharmacologic support.lld:pubmed
pubmed-article:6413087pubmed:languageenglld:pubmed
pubmed-article:6413087pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6413087pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6413087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6413087pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6413087pubmed:statusMEDLINElld:pubmed
pubmed-article:6413087pubmed:monthOctlld:pubmed
pubmed-article:6413087pubmed:issn0009-7322lld:pubmed
pubmed-article:6413087pubmed:authorpubmed-author:GunnarR MRMlld:pubmed
pubmed-article:6413087pubmed:authorpubmed-author:FreemanGGlld:pubmed
pubmed-article:6413087pubmed:authorpubmed-author:LoebH SHSlld:pubmed
pubmed-article:6413087pubmed:authorpubmed-author:WittJJlld:pubmed
pubmed-article:6413087pubmed:authorpubmed-author:ScanlonPPlld:pubmed
pubmed-article:6413087pubmed:authorpubmed-author:OstrengaJ PJPlld:pubmed
pubmed-article:6413087pubmed:authorpubmed-author:GaulWWlld:pubmed
pubmed-article:6413087pubmed:issnTypePrintlld:pubmed
pubmed-article:6413087pubmed:volume68lld:pubmed
pubmed-article:6413087pubmed:ownerNLMlld:pubmed
pubmed-article:6413087pubmed:authorsCompleteYlld:pubmed
pubmed-article:6413087pubmed:pagination813-20lld:pubmed
pubmed-article:6413087pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:6413087pubmed:meshHeadingpubmed-meshheading:6413087-...lld:pubmed
pubmed-article:6413087pubmed:meshHeadingpubmed-meshheading:6413087-...lld:pubmed
pubmed-article:6413087pubmed:meshHeadingpubmed-meshheading:6413087-...lld:pubmed
pubmed-article:6413087pubmed:meshHeadingpubmed-meshheading:6413087-...lld:pubmed
pubmed-article:6413087pubmed:meshHeadingpubmed-meshheading:6413087-...lld:pubmed
pubmed-article:6413087pubmed:meshHeadingpubmed-meshheading:6413087-...lld:pubmed
pubmed-article:6413087pubmed:meshHeadingpubmed-meshheading:6413087-...lld:pubmed
pubmed-article:6413087pubmed:meshHeadingpubmed-meshheading:6413087-...lld:pubmed
pubmed-article:6413087pubmed:meshHeadingpubmed-meshheading:6413087-...lld:pubmed
pubmed-article:6413087pubmed:meshHeadingpubmed-meshheading:6413087-...lld:pubmed
pubmed-article:6413087pubmed:meshHeadingpubmed-meshheading:6413087-...lld:pubmed
pubmed-article:6413087pubmed:meshHeadingpubmed-meshheading:6413087-...lld:pubmed
pubmed-article:6413087pubmed:meshHeadingpubmed-meshheading:6413087-...lld:pubmed
pubmed-article:6413087pubmed:meshHeadingpubmed-meshheading:6413087-...lld:pubmed
pubmed-article:6413087pubmed:year1983lld:pubmed
pubmed-article:6413087pubmed:articleTitleBeneficial effects of dopamine combined with intravenous nitroglycerin on hemodynamics in patients with severe left ventricular failure.lld:pubmed
pubmed-article:6413087pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6413087pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6413087pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:6413087pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed